BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29634072)

  • 1. [Treatment with metformin in type 2 diabetes mellitus - new routines when renal function is reduced and in connection with administration of iodine contrast media].
    Sterner G; Frid A
    Lakartidningen; 2018 Apr; 115():. PubMed ID: 29634072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New contraindication to intravascular iodinated contrast material.
    Dachman AH
    Radiology; 1995 Nov; 197(2):545. PubMed ID: 7480710
    [No Abstract]   [Full Text] [Related]  

  • 4. New contraindication to intravascular iodinated contrast material.
    Rotter A
    Radiology; 1995 Nov; 197(2):545-6. PubMed ID: 7480711
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.
    Thomsen HS; Morcos SK
    Eur Radiol; 1999; 9(4):738-40. PubMed ID: 10354898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proposal for the modification of metformin use in patients with chronic kidney disease].
    Balogh Z; Mátyus J
    Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES.
    Shah AD; McHargue C; Yee J; Rushakoff RJ
    Endocr Pract; 2016 Apr; 22(4):502-5. PubMed ID: 26789340
    [No Abstract]   [Full Text] [Related]  

  • 8. A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.
    Adam WR; O'Brien RC
    Diabet Med; 2014 Sep; 31(9):1032-8. PubMed ID: 24909998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining metformin prescribing in New Zealand.
    Jayathissa S; Dixon P; Bruce R; Reith D
    N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic kidney diseases, metformin and lactic acidosis].
    Borbély Z
    Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metformin and contrast media--increased risk of lactic acidosis?].
    Kløw NE; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1829. PubMed ID: 11464691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use in renal disease.
    Khan M; Siddiqui N
    J Pak Med Assoc; 2017 Aug; 67(8):1301. PubMed ID: 28839328
    [No Abstract]   [Full Text] [Related]  

  • 13. Range of therapeutic metformin concentrations in clinical blood samples and comparison to a forensic case with death due to lactic acidosis.
    Hess C; Unger M; Madea B; Stratmann B; Tschoepe D
    Forensic Sci Int; 2018 May; 286():106-112. PubMed ID: 29574345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why hold the metformin?
    King JE
    Nursing; 2004 Jul; 34(7):20. PubMed ID: 15241265
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of metformin in the setting of mild-to-moderate renal insufficiency.
    Lipska KJ; Bailey CJ; Inzucchi SE
    Diabetes Care; 2011 Jun; 34(6):1431-7. PubMed ID: 21617112
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lactic acidosis feared adverse effect of metformin treatment. New guidelines can increase vigilance].
    Berne C; Hietala SO
    Lakartidningen; 1999 Dec; 96(50):5598-9. PubMed ID: 10643216
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement.
    Hur KY; Kim MK; Ko SH; Han M; Lee DW; Kwon HS; ;
    Diabetes Metab J; 2020 Feb; 44(1):3-10. PubMed ID: 32097995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metformin in serum. Results of a study as basis for preliminary therapeutic recommendations].
    Frid A; Sterner G; Löndahl M; Vinge E; Cato A; Andersson A
    Lakartidningen; 2009 Feb 11-17; 106(7):428-9. PubMed ID: 19350768
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin hydrochloride all right before, but not after, contrast medium administration.
    Rasuli P; French GJ; Hammond DI
    Radiology; 1998 Nov; 209(2):586-7. PubMed ID: 9807597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.